Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05858749
What this trial is testing

Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 494
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Not applicableStudy completedNCT02499458
What this trial is testing

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

Who this might be right for
Clear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial Cells+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 44
Early research (Phase 1)Study completedNCT02035358
What this trial is testing

Immunotherapy Study for Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Clear-cell Renal CancerRecurrent Renal Cell Carcinoma+2 more
NewLink Genetics Corporation 18
Testing effectiveness (Phase 2)Looking for participantsNCT07023432
What this trial is testing

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

Who this might be right for
Active SurveillanceClear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 78
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Large-scale testing (Phase 3)Study completedNCT00053807
What this trial is testing

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

Who this might be right for
Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC 96
Testing effectiveness (Phase 2)Ended earlyNCT00277316
What this trial is testing

Study of XL999 in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Symphony Evolution, Inc. 11
Not applicableStudy completedNCT01836406
What this trial is testing

Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Yonsei University 16
Post-approval studies (Phase 4)Study completedNCT02555748
What this trial is testing

Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Cancer
Institut Claudius Regaud 47
Testing effectiveness (Phase 2)Study completedNCT00835978
What this trial is testing

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Pfizer 213
Not applicableTemporarily pausedNCT04669860
What this trial is testing

Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma

Who this might be right for
Calcium Oxalate UrolithiasisRenal Cell Carcinoma
University of Miami 90
Testing effectiveness (Phase 2)Study completedNCT01361113
What this trial is testing

Neoadjuvant Pazopanib in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center 21
Not applicableActive Not RecruitingNCT01582204
What this trial is testing

Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cancer
Memorial Sloan Kettering Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT01064310
What this trial is testing

Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 169
Testing effectiveness (Phase 2)Study completedNCT00664326
What this trial is testing

A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC

Who this might be right for
Carcinoma, Renal Cell
Bayer 49
Not applicableActive Not RecruitingNCT05863052
What this trial is testing

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Who this might be right for
Immune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more
University of Oklahoma 72
Very early researchStudy completedNCT05728515
What this trial is testing

A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 3
Not applicableEnded earlyNCT01598038
What this trial is testing

Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Centre Francois Baclesse 41
Next Page